Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?

by Lassman, Andrew B
Published in CNS Oncol (2015)

Newly diagnosed glioblastoma in the elderly: when is temozolomide alone enough?

by Haggiagi, Aya, Lassman, Andrew B
Published in Neuro Oncol (2020)

Factorial clinical trials: a new approach to phase II neuro-oncology studies

by Iwamoto, Fabio M., Lassman, Andrew B.
Published in Neuro Oncol (2015)

Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low Grade Gliomas?

by Schaff, Lauren R., Lassman, Andrew B.
Published in Semin Radiat Oncol (2015)

Biomarkers in NOA-04: another piece to the puzzle

by Lassman, Andrew B., Cloughesy, Timothy F.
Published in Neuro Oncol (2016)

NovoTTF: where to go from here?

by Cloughesy, Timothy F., Lassman, Andrew B.
Published in Neuro Oncol (2017)

Early results from the CODEL trial for anaplastic oligodendrogliomas: is temozolomide futile?

by Lassman, Andrew B, Cloughesy, Timothy F
Published in Neuro Oncol (2021)

ATIM-14. CMV gB/pp65 eVLPs FORMULATED WITH GM-CSF AS A THERAPEUTIC VACCINE AGAINST RECURRENT GLIOBLASTOMA (GBM)

by Iwamoto, Fabio, Diaz-Mitoma, Francisco, Anderson, David, Lassman, Andrew B
Published in Neuro Oncol (2018)

Current usage of tumor treating fields for glioblastoma

by Lassman, Andrew B, Joanta-Gomez, Adela E, Pan, Peter C, Wick, Wolfgang
Published in Neurooncol Adv (2020)

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

by Clarke, Jennifer L., Pao, William, Wu, Nian, Miller, Vincent A., Lassman, Andrew B.
Published 2010

ATIM-07. STUDY OF PEMBROLIZUMAB, TUMOR TREATMENT FIELDS (OPTUNE®) AND TEMOZOLOMIDE FOR OLDER SUBJECTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

by Donovan, Laura, Cieremans, David, Kreisl, Teri, Welch, Mary, Lassman, Andrew B, Iwamoto, Fabio
Published in Neuro Oncol (2017)

Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice

by Lassman, Andrew B., Dai, Chengkai, Fuller, Gregory N., Vickers, Andrew J., Holland, Eric C.
Published 2004

EPID-11. IDENTIFYING BARRIERS TO CLINICAL RESEARCH: A PILOT STUDY TO IMPROVE ACCESS AND ENROLLMENT TO NEURO-ONCOLOGY TRIALS AT COLUMBIA UNIVERSITY CENTER MEDICAL CENTER (CUMC)

by Welch, Mary, Segall, Leslie, Hillyer, Grace, Iwamoto, Fabio, Kreisl, Teri, Otap, Daniel, Lassman, Andrew B
Published in Neuro Oncol (2017)

QLIF-35. EFFECTS OF INTEGRATIVE THERAPIES ON DISTRESS, PAIN, AND FATIGUE IN PATIENTS WITH PRIMARY BRAIN TUMORS: PRELIMINARY RESULTS FROM AN INTEGRATIVE MEDICINE REGISTRY

by Donovan, Laura, Rusilowski, Angelica, Taromina, Katherine, Kreisl, Teri, Welch, Mary, Lassman, Andrew B, Ladas, Elena, Iwamoto, Fabio
Published in Neuro Oncol (2017)

IMCT-18 PD-1 INHIBITORS FOR RECURENT HIGH GRADE GLIOMA (HGG)

by Schaff, Lauren, Donovan, Laura, Lassman, Andrew B., Wang, Tony, Carvajal, Richard, Rizvi, Naiyer, Fox, Alyson, Iwamoto, Fabio M.
Published in Neuro Oncol (2015)

Magnetic Resonance Imaging‐Based Screening for Asymptomatic Brain Tumors: A Review

by Neugut, Alfred I., Sackstein, Paul, Hillyer, Grace C., Jacobson, Judith S., Bruce, Jeffrey, Lassman, Andrew B., Stieg, Philip A.
Published in Oncologist (2018)

ET-53 IPILIMUMAB FOR RECURRENT GLIOBLASTOMA (GBM)

by Schaff, Lauren R., Lassman, Andrew B., Goldlust, Samuel A., Cloughesy, Timothy, Singer, Samuel, Schwartz, Gary K., Iwamoto, Fabio M.
Published 2014

INNV-06. FACTORS INFLUENCING RECEPTIVITY TO CLINICAL RESEARCH IN AN URBAN NEURO-ONCOLOGY PRACTICE

by Welch, Mary, Conway, Grant, Hillyer, Grace, Segall, Leslie, Otap, Dan, Donovan, Laura, Kreisl, Teri, Iwamoto, Fabio, Lassman, Andrew B
Published in Neuro Oncol (2018)

ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

by Bahng, Hye Hyun, Green, Stacey, Lai, Albert, Hu, Jethro, Green, Richard, Iwamoto, Fabio, Lassman, Andrew B, Cloughesy, Timothy, Nghiemphu, Phioanh
Published in Neuro Oncol (2017)

LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER...

by Kumthekar, Priya, Lassman, Andrew B, Lin, Nancy, Grimm, Sean, Gradishar, William, Pentsova, Elena, Jeyapalan, Suriya, Groves, Morris, Melisko, Melissa, Raizer, Jeffrey
Published in Neurooncol Adv (2019)